Search Results - "Cotter, F. E."

Refine Results
  1. 1

    Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma by WATERS, J. S, WEBB, A, CUNNINGHAM, D, CLARKE, P. A, RAYNAUD, F, DI STEFANO, F, COTTER, F. E

    Published in Journal of clinical oncology (01-05-2000)
    “…To evaluate the pharmacokinetics and toxicity of an antisense oligonucleotide targeting bcl-2 in patients with non-Hodgkin's lymphoma (NHL) and to determine…”
    Get full text
    Journal Article
  2. 2

    t(11;18)(q21;q21) is the most common translocation in MALT lymphomas by Auer, I. A., Gascoyne, R. D., Conners, J. M., Cotter, F. E., Greiner, T. C., Sanger, W. G., Horsman, D. E.

    Published in Annals of oncology (01-10-1997)
    “…Background Low grade malignant lymphomas arising from mucosa associated lymphoid tissue (MALT) represent a distinct clinicopathological entity. The cytogenetic…”
    Get full text
    Journal Article
  3. 3

    Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species by FENNELL, D. A, CORBO, M, PALLASKA, A, COTTER, F. E

    Published in British journal of cancer (18-05-2001)
    “…Resistance to apoptosis is a major obstacle preventing effective therapy for malignancy. Mitochondria localized anti-death proteins of the Bcl-2 family play a…”
    Get full text
    Journal Article
  4. 4

    Monosomy 7 and 7q- associated with myeloid malignancy by Johnson, E., Cotter, F.E.

    Published in Blood reviews (01-03-1997)
    “…An association between the complete or partial loss of chromosome 7 and preleukaemic myelodysplasia or acute myeloid leukaemia has been recognized from the…”
    Get full text
    Journal Article
  5. 5

    The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma by Price, C G, Meerabux, J, Murtagh, S, Cotter, F E, Rohatiner, A Z, Young, B D, Lister, T A

    Published in Journal of clinical oncology (01-09-1991)
    “…Peripheral blood mononuclear cell fractions from 15 patients in continuous clinical remission from follicular lymphoma for longer than 10 years were examined…”
    Get more information
    Journal Article
  6. 6

    Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model by Cotter, F E, Johnson, P, Hall, P, Pocock, C, al Mahdi, N, Cowell, J K, Morgan, G

    Published in Oncogene (01-10-1994)
    “…The t(14;18) translocation is found in the majority follicular lymphomas and some high grade B-cell lymphomas. This is results in deregulation of the BCL-2…”
    Get more information
    Journal Article
  7. 7

    Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma by Johnson, P W, Price, C G, Smith, T, Cotter, F E, Meerabux, J, Rohatiner, A Z, Young, B D, Lister, T A

    Published in Journal of clinical oncology (01-04-1994)
    “…To use the polymerase chain reaction (PCR) technique for molecular assessment of the results of myeloablative treatment of follicular lymphoma with autologous…”
    Get more information
    Journal Article
  8. 8

    Molecular Definition of a Narrow Interval at 7q22.1 Associated With Myelodysplasia by Johnson, E.J., Scherer, S.W., Osborne, L, Tsui, L.C., Oscier, D., Mould, S., Cotter, F.E.

    Published in Blood (01-05-1996)
    “…Chromosome 7 translocations, deletions, or monosomy are associated with myelodysplasia (MDS) and acute myeloid leukemia both in children and adults. These…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Stochastic modelling of apoptosis kinetics by Fennell, D A, Pallaska, A, Corbo, M, Cotter, F E

    Published in Apoptosis (London) (01-03-2005)
    “…Robust quantitative estimation of average whole cell mitochondrial dysfunction is a useful tool for assessing sensitivity to apoptotic stimuli induced either…”
    Get full text
    Journal Article
  11. 11

    Antisense therapy of hematologic malignancies by Cotter, F E

    Published in Seminars in hematology (01-10-1999)
    “…Many tumor cells are inherently resistant to curative treatment due to an altered pattern of gene expression. It is an attractive and logical proposition to…”
    Get more information
    Journal Article
  12. 12
  13. 13

    The class II tumour suppressor gene RARRES3 maps to 11q12, not 11q23 by Auer, R L, Bertoni, F, Jones, C, Cotter, F E

    Published in Leukemia (01-07-2002)
    “…Leukemia (2002) 16, 1396. doi:10.1038/sj.leu.2402505…”
    Get full text
    Journal Article
  14. 14

    Genetic alteration associated with chronic lymphocytic leukemia by Cotter, F E, Auer, R L

    Published in Cytogenetic and genome research (01-01-2007)
    “…The genetics of B-cell chronic lymphocytic leukemia (B-CLL) differ considerably from most other forms of hematologic malignancy which are usually characterized…”
    Get more information
    Journal Article
  15. 15

    Early postischemic dantrolene-induced amelioration of poly(ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices by Tasker, R C, Sahota, S K, Cotter, F E, Williams, S R

    “…In the infant brain, ischemia-induced ionic and enzyme mechanisms may independently lead to cell death by energy depletion: resequestration of calcium…”
    Get more information
    Journal Article
  16. 16

    Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-XL and Mcl-1 expressing human cholangiocarcinoma cells by Okaro, A C, Fennell, D A, Corbo, M, Davidson, B R, Cotter, F E

    Published in Gut (01-10-2002)
    “…Background: Cholangiocarcinoma cells express high levels of the antiapoptotic proteins Bcl-XL and Mcl-1 and are markedly chemo- and radioresistant…”
    Get full text
    Journal Article
  17. 17

    Antisense therapy for lymphomas by Cotter, Finbarr E.

    Published in Hematological oncology (01-02-1997)
    “…The potential ability of antisense oligonucleotides to downregulate the expression of oncogenes involved in lymphoma, with minimal toxicity can be achieved…”
    Get full text
    Journal Article
  18. 18

    BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation by Pocock, C F, Malone, M, Booth, M, Evans, M, Morgan, G, Greil, J, Cotter, F E

    Published in British journal of haematology (01-08-1995)
    “…Acute leukaemia of infancy is associated with abnormalities at chromosome band 11q23, and has a poor prognosis. The gene involved. Mixed Lineage Leukaemia…”
    Get more information
    Journal Article
  19. 19
  20. 20

    An immunohistological and genotypic study of the plasma cell form of Castleman's disease by Hall, P A, Donaghy, M, Cotter, F E, Stansfeld, A G, Levison, D A

    Published in Histopathology (01-04-1989)
    “…The plasma cell variant of Castleman's disease (angiofollicular hyperplasia) is an uncommon and poorly understood lymphoproliferative disorder which may be…”
    Get more information
    Journal Article